<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01694953</url>
  </required_header>
  <id_info>
    <org_study_id>AAAI5453</org_study_id>
    <secondary_id>1U54NS078059</secondary_id>
    <nct_id>NCT01694953</nct_id>
  </id_info>
  <brief_title>The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)</brief_title>
  <acronym>NAHIM</acronym>
  <official_title>The Rare Disease Clinical Research Network Natural History Study of MNGIE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center natural history study of MNGIE (Mitochondrial NeurogastroIntestinal
      Encephalopathy). Patients will be followed over time to assess clinical symptoms. The
      investigators hope to learn more about the disease of MNGIE as well as develop useful
      measures of disease status for use in future clinical trials.

      Additional clinical centers will be listed as they become available.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will examine a total of 20 patients at six month intervals for up to five
      years. The investigators will evaluate gastrointestinal function, lean body mass, neuropathy,
      neuropsychological capability, quality of life, nutrition, motor function and biochemical
      parameters.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Timed Water Swallow</measure>
    <time_frame>5 years</time_frame>
    <description>The timed water swallow test evaluates the time it takes to swallow a small cup of water</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Degree of Neuropathy</measure>
    <time_frame>5 years</time_frame>
    <description>A general neurological exam will be performed to assess the degree of neuropathy.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Score on Mini Mental State Exam</measure>
    <time_frame>5 years</time_frame>
    <description>A short assessment of cognitive function will be performed.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)</condition>
  <arm_group>
    <arm_group_label>Patients with MNGIE</arm_group_label>
    <description>Patients of all races of any gender who are at least 5 years of age with a defect in thymidine phosphorylase may participate in this natural history study.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Male or female, At least 5 years of age, with Thymidine Phosphorylase defect
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Thymidine Phosphorylase (TP) defect:

               1. homozygous or

               2. compound heterozygous mutations in the TYMP gene, and/or

               3. TP enzyme activity of &lt;20% of normal.

          2. Increased plasma Thd &gt; 3 micromole/L

          3. Increased plasma dUrd &gt; 7.5 micromole/L

          4. Age requirement of at least 5 years of age.

        Exclusion Criteria:

          1. Participation in an interventional (study medication or other experimental
             intervention) study (within 1 month of participation in this study).

          2. Unable to travel to site for research visits.

          3. Unwillingness to sign informed consent form.

          4. Substance abuser
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michio Hirano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kris Engelstad, MS</last_name>
    <phone>12123056834</phone>
    <email>NAMDC@columbia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York City</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kris Engelstad, MS</last_name>
      <phone>212-305-6834</phone>
      <email>ke4@columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Michio Hirano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Martí R, López LC, Hirano M. Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity. Methods Mol Biol. 2012;837:121-33. doi: 10.1007/978-1-61779-504-6_8.</citation>
    <PMID>22215544</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2012</study_first_submitted>
  <study_first_submitted_qc>September 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2012</study_first_posted>
  <last_update_submitted>August 8, 2016</last_update_submitted>
  <last_update_submitted_qc>August 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Michio Hirano</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <keyword>MNGIE</keyword>
  <keyword>Mitochondrial</keyword>
  <keyword>Mitochondrial Neurogastrointestinal encephalopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>When applicable manuscript (s) will be submitted</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

